COMPARATIVE EFFECTS OF THE ORAL-CONTRACEPTIVE COMBINATIONS 0.150 MG DESOGESTREL + 0.030 MG ETHINYLESTRADIOL AND 0.150 MG LEVONORGESTREL + 0.030 MG ETHINYLESTRADIOL ON LIPID AND LIPOPROTEIN METABOLISM IN HEALTHY FEMALE VOLUNTEERS

被引：34

|

作者：

SAMSIOE, G

机构：

来源：

CONTRACEPTION | 1982年 / 25卷 / 05期

关键词：

D O I：

10.1016/0010-7824(82)90038-5

中图分类号：

R71 [妇产科学];

学科分类号：

100211 ;

摘要：

引用

收藏

页码：487 / 504

页数：18

相关论文

共 40 条

[1] SCANDINAVIAN TRIAL OF AN ORAL-CONTRACEPTIVE CONTAINING 0.150 MG DESOGESTREL AND 0.030 MG ETHINYLESTRADIOL
BORGLIN, NE
CHRISTENSEN, OJE
CULLBERG, G
ENGER, L
FJAERESTAD, I
KLOTTRUP, P
ODLIND, V
SANDAGER, T
SECHER, K
ASSENDORP, R
[J]. ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 1982, : 39 - 42
[2] EFFECTS OF THE ORAL-CONTRACEPTIVE COMBINATION 0.150-MG DESOGESTREL PLUS 0.020-MG ETHINYLESTRADIOL ON CARBOHYDRATE-METABOLISM IN HEALTHY FEMALE VOLUNTEERS
VANDENENDE, A
LUTJENS, A
VANWAYJEN, RGA
KLOOSTERBOER, HJ
[J]. ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 1987, : 29 - 32
[3] ROUTINE LIVER-FUNCTION TESTING DURING LONG-TERM ADMINISTRATION OF THE ORAL-CONTRACEPTIVE PREPARATION 0.150 MG DESOGESTREL PLUS 0.030 MG ETHINYLESTRADIOL TO HEALTHY FEMALE VOLUNTEERS IN SCANDINAVIA
ODLIND, V
BORGLIN, NE
CHRISTENSEN, OJE
CULLBERG, G
ENGER, L
FJAERESTAD, I
KLOTTRUP, P
SANDAGER, T
SECHER, K
[J]. ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 1982, : 43 - 46
[4] EFFECTS OF 2 ORAL-CONTRACEPTIVE COMBINATIONS, 0.125 MG DESOGESTREL + 0.050 MG ETHINYLESTRADIOL AND 0.125 MG LEVONORGESTREL + 0.050 MG ETHINYLESTRADIOL ON THE ADRENAL-FUNCTION OF HEALTHY FEMALE VOLUNTEERS
RUOKONEN, A
LUND, L
NUMMI, S
ALAPIESSA, U
VIINIKKA, L
[J]. EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 1982, 13 (04): : 259 - 265
[5] BELGIAN TRIAL OF AN ORAL-CONTRACEPTIVE CONTAINING 0.150-MG DESOGESTREL AND 0.020-MG ETHINYLESTRADIOL
VANKETS, HE
[J]. ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 1987, : 13 - 17
[6] GERMAN TRIAL OF AN ORAL-CONTRACEPTIVE CONTAINING 0.150-MG DESOGESTREL PLUS 0.020-MG ETHINYLESTRADIOL
NEVINNYSTICKEL, J
[J]. ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 1987, : 19 - 21
[7] A CLINICAL COMPARISON IN FINLAND OF 2 ORAL-CONTRACEPTIVES CONTAINING 0.150-MG DESOGESTREL IN COMBINATION WITH 0.020-MG OR 0.030-MG ETHINYLESTRADIOL
TUIMALA, R
SARANEN, M
ALAPIESSA, U
[J]. ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 1987, : 7 - 12
[8] EFFECTS OF THE ORAL-CONTRACEPTIVE COMBINATION 0.150-MG DESOGESTREL +0.020-MG ETHINYLESTRADIOL ON SERUM-LIPIDS INCLUDING THE HDL SUBFRACTIONS
KLOOSTERBOER, HJ
VANWAYJEN, RGA
VANDENENDE, A
[J]. ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 1987, : 33 - 36
[9] EVALUATION OF AN ORAL-CONTRACEPTIVE CONTAINING 0.150-MG DESOGESTREL AND 0.020-MG ETHINYLESTRADIOL IN WOMEN AGED 30 YEARS OR OLDER
STEFFENSEN, K
[J]. ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 1987, : 23 - 27
[10] CLINICAL-STUDIES WITH A NEW, LOW-DOSE ORAL-CONTRACEPTIVE COMBINATION, CONTAINING 0.150 MG DESOGESTREL AND 0.020 MG ETHINYLESTRADIOL - FOREWORD
ALAPIESSA, U
LOK, D
[J]. ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 1987, : 5 - 5

← 1 2 3 4 →